Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas
CompletedOBSERVATIONAL
Enrollment
65
Participants
Timeline
Start Date
January 1, 2002
Primary Completion Date
October 1, 2021
Study Completion Date
November 1, 2021
Conditions
Lymphoma, B-Cell
Trial Locations (1)
34295
Uh Montpellier, Montpellier
All Listed Sponsors
lead
University Hospital, Montpellier
OTHER
NCT05133505 - Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas | Biotech Hunter | Biotech Hunter